Antipsychotic medications: a timeline of innovations and remaining challenges
Summary
This research paper outlines the evolution of antipsychotic drugs from the first introduction of chlorpromazine in 1954 to the 2024 approval of xanomeline-trospium. It finds that while newer drugs are generally safer and more effective against a broader range of symptoms, significant challenges remain regarding cognitive symptoms and long-term metabolic side effects.
Key insights
- Antipsychotic medications are categorized into 'conventional' and 'atypical' groups, primarily distinguished by their side effects; conventional drugs often cause movement-related issues like spasms and tremors, whereas atypical antipsychotics are less likely to do so.
- Chlorpromazine, introduced in the United States in 1954, was the first antipsychotic drug and led to the 'dopamine theory' of schizophrenia, which posited that the condition was caused by excess dopamine in the brain.
- Clozapine, introduced in the US in 1990, challenged the belief that movement-related side effects were inevitable for efficacy, as it showed benefits for both psychosis and 'negative symptoms' with lower dopamine receptor action.
- Despite improvements, most current antipsychotics struggle to treat 'negative symptoms' (emotional blunting, social withdrawal) and 'cognitive symptoms' (disorganized thoughts, memory, and attention).
- Many modern antipsychotic drugs carry risks of long-term complications, including weight gain, diabetes, metabolic problems, and cardiovascular disease.
- The 2024 approved medication xanomeline-trospium targets muscarinic receptors rather than dopamine receptors and has demonstrated efficacy against a broader range of schizophrenia symptoms without causing movement, metabolic, or weight-gain side effects.
Cite the original document
- APA
- Dattani, S. (2024). Antipsychotic medications: a timeline of innovations and remaining challenges. Our World in Data. https://ourworldindata.org/antipsychotic-medications-timeline
- Chicago
- Dattani, Saloni. Antipsychotic medications: a timeline of innovations and remaining challenges. Our World in Data, 2024. https://ourworldindata.org/antipsychotic-medications-timeline.
- Wikipedia
- {{cite report |last1=Dattani |first1=Saloni |title=Antipsychotic medications: a timeline of innovations and remaining challenges |publisher=Our World in Data |date=26 August 2024 |url=https://ourworldindata.org/antipsychotic-medications-timeline |access-date=5 November 2026 |via=Climate Insights Directory (document owid-000023)}}
- BibTeX
- @techreport{dattani2024antipsychotic, author = {Dattani, Saloni}, title = {{Antipsychotic medications: a timeline of innovations and remaining challenges}}, institution = {Our World in Data}, year = {2024}, month = aug, url = {https://ourworldindata.org/antipsychotic-medications-timeline}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document owid-000023} }
Full text
Collected · Record updated